Stay updated on ASLAN004 SubQ in Atopic Dermatitis: Safety Clinical Trial.
Sign up to get notified when there's something new on the ASLAN004 SubQ in Atopic Dermatitis: Safety Clinical Trial. page.

Latest updates to the ASLAN004 SubQ in Atopic Dermatitis: Safety Clinical Trial. page
- CheckyesterdayChange DetectedNo additions or deletions were detected; the page's core content and study details remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange Detected- Updated version from v3.1.0 to v3.2.0. - Added a government-operating-status notice about funding lapse and the NIH Clinical Center openness, directing users to cc.nih.gov and opm.gov for status updates.SummaryDifference3%

- Check30 days agoChange DetectedUpdate the page's version identifier from v3.0.2 to v3.1.0.SummaryDifference0.1%

- Check44 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2; 'Back to Top' was removed.SummaryDifference0.2%

- Check51 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.2%

- Check58 days agoChange DetectedThe web page has added significant information regarding a facility, its location, and relevant publications, while removing specific geographic details and references to eczema.SummaryDifference5%

Stay in the know with updates to ASLAN004 SubQ in Atopic Dermatitis: Safety Clinical Trial.
Enter your email address, and we'll notify you when there's something new on the ASLAN004 SubQ in Atopic Dermatitis: Safety Clinical Trial. page.